# Momentus Inc.: filings

MNTS · Nasdaq · CIK 1781162 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnts.md) · [Financials](/companies/mnts/financials.md) · [Filings](/companies/mnts/filings.md) · [Insiders](/companies/mnts/insiders.md)

## Reports and events: 242 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 160, 4 146, 425 51, CORRESP 30, 3 26, 424B3 24, UPLOAD 23, 10-Q 20, SC 13G/A 19, EFFECT 18, 424B5 17, DEF 14A 14, S-1 14, SC 13G 14, 144 11, PRE 14A 11, DEFA14A 10, S-8 10, S-1/A 9, SC 13D/A 9, 10-K 7, S-4/A 6, SCHEDULE 13G/A 6, NT 10-Q 5, S-3 5, SCHEDULE 13G 5, 144/A 4, 10-K/A 3, 4/A 3, 8-K/A 3, DRS 3, 25-NSE 2, 424B4 2, 424B7 2, ARS 2, D 2, DRSLTR 2, NT 10-K 2, SC 13D 2, 10-Q/A 1, 8-A12B 1, CERT 1, POS AM 1, PRER14A 1, S-3/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-25 | 16:52 ET | [8-K](/filings/0001628280-26-058934.md) | 1.02 Termination of a material agreement | 0001628280-26-058934 |
| 2026-08-14 | 16:01 ET | [8-K](/filings/0001140361-26-033135.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-26-033135 |
| 2026-08-11 | 14:23 ET | [10-Q](/filings/0001628280-26-055624.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055624 |
| 2026-06-18 | 16:45 ET | [8-K](/filings/0001140361-26-025776.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-025776 |
| 2026-06-15 | 17:02 ET | [8-K](/filings/0001140361-26-025252.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025252 |
| 2026-05-29 | 16:51 ET | [8-K](/filings/0001140361-26-023337.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-023337 |
| 2026-05-22 | 06:01 ET | [8-K](/filings/0001140361-26-022497.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-022497 |
| 2026-05-13 | 14:12 ET | [10-Q](/filings/0001628280-26-034490.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034490 |
| 2026-05-05 | 08:47 ET | [8-K](/filings/0001140361-26-019009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-019009 |
| 2026-04-20 | 11:35 ET | [8-K](/filings/0001140361-26-015530.md) | 1.02 Termination of a material agreement | 0001140361-26-015530 |
| 2026-04-16 | 09:25 ET | [8-K](/filings/0001140361-26-014988.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-014988 |
| 2026-04-13 | 08:52 ET | [8-K](/filings/0001140361-26-014365.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-014365 |
| 2026-04-10 | 17:20 ET | [DEF 14A](/filings/0001140361-26-014277.md) | Proxy statement, period 2026-05-19 | 0001140361-26-014277 |
| 2026-03-31 | 12:41 ET | [10-K](/filings/0001628280-26-022291.md) | Annual report, period 2025-12-31 | 0001628280-26-022291 |
| 2026-02-20 | 16:56 ET | [8-K](/filings/0001140361-26-006335.md) | 8.01 Other events | 0001140361-26-006335 |
| 2026-02-12 | 14:55 ET | [8-K](/filings/0001140361-26-004972.md) | 5.07 Shareholder vote results | 0001140361-26-004972 |
| 2026-01-22 | 09:07 ET | [DEF 14A](/filings/0001140361-26-002047.md) | Proxy statement, period 2026-02-06 | 0001140361-26-002047 |
| 2026-01-13 | 19:00 ET | [8-K](/filings/0001140361-26-001016.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001140361-26-001016 |
| 2026-01-09 | 17:07 ET | [8-K](/filings/0001140361-26-000853.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000853 |
| 2025-12-29 | 09:55 ET | [DEF 14A](/filings/0001140361-25-046747.md) | Proxy statement, period 2026-01-27 | 0001140361-25-046747 |
| 2025-12-29 | 14:02 ET | [8-K](/filings/0001140361-25-046720.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001140361-25-046720 |
| 2025-12-19 | 17:27 ET | [S-1](/filings/0001140361-25-046231.md) | Registration statement | 0001140361-25-046231 |
| 2025-12-15 | 11:50 ET | [8-K](/filings/0001140361-25-045491.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-045491 |
| 2025-12-12 | 10:11 ET | [8-K](/filings/0001140361-25-045310.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-045310 |
| 2025-12-10 | 08:34 ET | [8-K](/filings/0001140361-25-045087.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001140361-25-045087 |
| 2025-11-24 | 16:06 ET | [8-K](/filings/0001140361-25-043134.md) | 8.01 Other events | 0001140361-25-043134 |
| 2025-11-20 | 17:36 ET | [10-Q](/filings/0001781162-25-000041.md) | Quarterly report, period 2025-09-30 | 0001781162-25-000041 |
| 2025-10-29 | 10:40 ET | [DEF 14A](/filings/0001140361-25-039712.md) | Proxy statement, period 2025-11-24 | 0001140361-25-039712 |
| 2025-10-27 | 19:51 ET | [S-1](/filings/0001140361-25-039325.md) | Registration statement | 0001140361-25-039325 |
| 2025-10-24 | 16:50 ET | [S-1](/filings/0001140361-25-039284.md) | Registration statement | 0001140361-25-039284 |
| 2025-10-17 | 17:18 ET | [S-1/A](/filings/0001140361-25-038519.md) | Registration statement, amended | 0001140361-25-038519 |
| 2025-10-15 | 16:15 ET | [8-K](/filings/0001140361-25-038203.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-038203 |
| 2025-10-09 | 08:30 ET | [8-K](/filings/0001140361-25-037763.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-037763 |
| 2025-10-06 | 17:08 ET | [8-K](/filings/0001140361-25-037391.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-037391 |
| 2025-10-01 | 07:30 ET | [8-K](/filings/0001140361-25-036869.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-036869 |
| 2025-09-29 | 17:06 ET | [8-K](/filings/0001140361-25-036535.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-036535 |
| 2025-09-25 | 16:05 ET | [8-K](/filings/0001140361-25-036125.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-036125 |
| 2025-09-18 | 17:27 ET | [8-K](/filings/0001140361-25-035420.md) | 5.07 Shareholder vote results | 0001140361-25-035420 |
| 2025-09-15 | 18:24 ET | [S-1](/filings/0001140361-25-034922.md) | Registration statement | 0001140361-25-034922 |
| 2025-09-11 | 21:20 ET | [8-K](/filings/0001140361-25-034600.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-034600 |
| 2025-09-08 | 08:27 ET | [DEF 14A](/filings/0001140361-25-034316.md) | Proxy statement, period 2025-09-17 | 0001140361-25-034316 |
| 2025-08-19 | 17:28 ET | [10-Q](/filings/0001628280-25-040834.md) | Quarterly report, period 2025-06-30 | 0001628280-25-040834 |
| 2025-08-19 | 17:36 ET | [DEF 14A](/filings/0001140361-25-031783.md) | Proxy statement, period 2025-09-17 | 0001140361-25-031783 |
| 2025-08-14 | 08:00 ET | [8-K](/filings/0001140361-25-031042.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-031042 |
| 2025-08-06 | 16:07 ET | [8-K](/filings/0001140361-25-029141.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-029141 |
| 2025-07-02 | 15:26 ET | [8-K](/filings/0001140361-25-024623.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-024623 |
| 2025-06-30 | 09:25 ET | [8-K](/filings/0001140361-25-024111.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-024111 |
| 2025-06-25 | 08:42 ET | [8-K](/filings/0001140361-25-023559.md) | 3.01 Delisting notice | 0001140361-25-023559 |
| 2025-06-23 | 21:41 ET | [S-1/A](/filings/0001140361-25-023226.md) | Registration statement, amended | 0001140361-25-023226 |
| 2025-06-20 | 17:01 ET | [8-K](/filings/0001140361-25-023204.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-023204 |

Page 1 of 5. [Older](/companies/mnts/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
